Pleio Says Omnibus Rule is Positive for Medication Adherence, Positive for Health Literacy, Positive for Pharmacy, as Program Sponsorships Double in 2013

Share Article

Pleio Health Support Systems is encouraged by the Omnibus Rule issued by the Department of Health and Human Services. The Rule confirms the vital role of pharmacy-driven medication adherence programs as part of health care treatment and operations under HIPAA.

Pleio Health Support Systems is encouraged by the Omnibus Rule issued by the Department of Health and Human Services. The Rule confirms the vital role of pharmacy-driven medication adherence programs as part of health care treatment and operations under HIPAA. Patients with low health literacy, patients who live in isolation, and overburdened caregivers will continue to benefit from Pleio’s phone-based GoodStart® programs delivered by pharmacies across the country. Patients must be properly informed and provide their verbal or written authorization – a practice that Pleio has implemented with its 40 pharmacy chain partners since 2009.

Low health literacy is directly associated with poor medication adherence. Through verbal explanations and digital authorizations enabled by HIPAA and the federal E-Sign Act, patients with low literacy can gain access to trusted support where and when they need it, in language they can understand. Since 2009, Pleio has helped more than 15,000 pharmacies implement phone-based support programs for their patients, in turn helping millions of Americans who prefer spoken more than written words. The Omnibus Rule’s new requirements take effect on September 23, 2013.

About Pleio Health Support Systems, Inc.
Pleio brings people together to develop and promote the world’s best solutions to the biggest challenge of medicine: medication adherence. Pleio GoodStart® is a registered trademark of Pleio Health Support Systems, Inc.

MEDIA CONTACT:     
Jean Lalonde, CEO
Jean(at)Pleio(dot)com
956-566-5729

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Mike Fiorentino

Jean Lalonde
Follow us on
Visit website